[go: up one dir, main page]

WO2001088168A3 - Mise en correspondance d'interactions moleculaires dans des plantes et d'analyses de complementation de fragments de proteine - Google Patents

Mise en correspondance d'interactions moleculaires dans des plantes et d'analyses de complementation de fragments de proteine Download PDF

Info

Publication number
WO2001088168A3
WO2001088168A3 PCT/US2001/015170 US0115170W WO0188168A3 WO 2001088168 A3 WO2001088168 A3 WO 2001088168A3 US 0115170 W US0115170 W US 0115170W WO 0188168 A3 WO0188168 A3 WO 0188168A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
plants
protein fragments
molecular interactions
complementation assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/015170
Other languages
English (en)
Other versions
WO2001088168A2 (fr
Inventor
Stephen W Michnick
Normand Brisson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Odyssey Pharmaceuticals Inc
Original Assignee
Odyssey Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Odyssey Pharmaceuticals Inc filed Critical Odyssey Pharmaceuticals Inc
Priority to AU2001261408A priority Critical patent/AU2001261408A1/en
Publication of WO2001088168A2 publication Critical patent/WO2001088168A2/fr
Publication of WO2001088168A3 publication Critical patent/WO2001088168A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une méthode permettant d'exprimer des partenaires d'interaction pour essais de complémentation de fragments de protéines (PCA) dans un matériau végétal. Cette méthode consiste à : (A) transformer ledit matériau avec (1) une première construction codant pour un premier produit de fusion qui comprend (a) un premier fragment d'une première molécule dont les fragments peuvent présenter une activité détectable lorsqu'ils sont associés et (b) un premier domaine d'interaction protéine-protéine ; et (2) une seconde construction codant pour un second produit de fusion qui comprend (a) un second fragment de ladite première molécule et (b) un second domaine d'interaction protéine-protéine qui peut se lier avec (1)(b) ; (B) cultiver ledit matériau dans des conditions permettent l'expression desdits partenaires d'interaction PCA ; et (C) détecter ladite activité.
PCT/US2001/015170 2000-05-12 2001-05-11 Mise en correspondance d'interactions moleculaires dans des plantes et d'analyses de complementation de fragments de proteine Ceased WO2001088168A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001261408A AU2001261408A1 (en) 2000-05-12 2001-05-11 Mapping molecular interactions in plants with protein fragments complementation assays

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20393700P 2000-05-12 2000-05-12
US60/203,937 2000-05-12

Publications (2)

Publication Number Publication Date
WO2001088168A2 WO2001088168A2 (fr) 2001-11-22
WO2001088168A3 true WO2001088168A3 (fr) 2002-04-25

Family

ID=22755898

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/015170 Ceased WO2001088168A2 (fr) 2000-05-12 2001-05-11 Mise en correspondance d'interactions moleculaires dans des plantes et d'analyses de complementation de fragments de proteine

Country Status (2)

Country Link
AU (1) AU2001261408A1 (fr)
WO (1) WO2001088168A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064769A1 (en) * 2000-10-05 2002-05-30 Watson Michnick Stephen William Dynamic visualization of expressed gene networks in living cells
EP1601576A4 (fr) * 2003-03-03 2007-12-05 Univ Columbia Systemes de biomarquage ligand/partenaire de liaison
JP5933700B2 (ja) * 2011-06-07 2016-06-15 フラウンホーファー−ゲゼルシャフト ツル フェルデルング デル アンゲヴァンテン フォルシュング エー ファウＦｒａｕｎｈｏｆｅｒ−Ｇｅｓｅｌｌｓｃｈａｆｔ ｚｕｒ Ｆｏｅｒｄｅｒｕｎｇ ｄｅｒ ａｎｇｅｗａｎｄｔｅｎ Ｆｏｒｓｃｈｕｎｇ ｅ．Ｖ． 単クローン性植物細胞系を生成させるための方法
WO2024103117A1 (fr) * 2022-11-16 2024-05-23 Commonwealth Scientific And Industrial Research Organisation Essai de criblage de protoplastes

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034120A1 (fr) * 1997-01-31 1998-08-06 Universite De Montreal Analyses par complementation de fragments proteiques pour detecter des interactions biomoleculaires
WO1998037211A1 (fr) * 1997-02-21 1998-08-27 Gene Shears Pty. Limited Complementation proteinique dans des plantes transgeniques
WO1998044350A1 (fr) * 1997-04-02 1998-10-08 The Board Of Trustees Of The Leland Stanford Junior University Detection d'interactions moleculaires par complementation de sous-unites de marquage
WO2000007038A2 (fr) * 1998-07-30 2000-02-10 Universite De Montreal Dosages de complementation proteines-fragments pour la detection d'interactions biologiques ou entre medicaments
WO2000071701A1 (fr) * 1999-05-24 2000-11-30 New England Biolabs, Inc. Procede de generation de genes non transferables separes capables d'exprimer un produit proteique actif
WO2001059091A2 (fr) * 2000-02-11 2001-08-16 Metabolix, Inc. Constructions a expression de genes mutiples contenant des inteines modifiees
WO2001094617A2 (fr) * 2000-06-02 2001-12-13 Odyssey Pharmaceuticals, Inc. Essai de complementation de fragment de proteine a base de beta-lactamase du tem-1 d'e. coli pour la detection des interactions entre proteine et proteine, proteine et petite molecule, et proteine et acide nucleique

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034120A1 (fr) * 1997-01-31 1998-08-06 Universite De Montreal Analyses par complementation de fragments proteiques pour detecter des interactions biomoleculaires
WO1998037211A1 (fr) * 1997-02-21 1998-08-27 Gene Shears Pty. Limited Complementation proteinique dans des plantes transgeniques
WO1998044350A1 (fr) * 1997-04-02 1998-10-08 The Board Of Trustees Of The Leland Stanford Junior University Detection d'interactions moleculaires par complementation de sous-unites de marquage
WO2000007038A2 (fr) * 1998-07-30 2000-02-10 Universite De Montreal Dosages de complementation proteines-fragments pour la detection d'interactions biologiques ou entre medicaments
WO2000071701A1 (fr) * 1999-05-24 2000-11-30 New England Biolabs, Inc. Procede de generation de genes non transferables separes capables d'exprimer un produit proteique actif
WO2001059091A2 (fr) * 2000-02-11 2001-08-16 Metabolix, Inc. Constructions a expression de genes mutiples contenant des inteines modifiees
WO2001094617A2 (fr) * 2000-06-02 2001-12-13 Odyssey Pharmaceuticals, Inc. Essai de complementation de fragment de proteine a base de beta-lactamase du tem-1 d'e. coli pour la detection des interactions entre proteine et proteine, proteine et petite molecule, et proteine et acide nucleique

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Clonal selection and mapping of the functional relationships among plant genes with a protein fragment complementation strategy", 1999-2000 GENOMICS PROJECTS COMPETITION RESULTS - NSERC, XP002189156, Retrieved from the Internet <URL:http://www.nserc.ca/programs/genres00_e.htm> *
PELLETIER, J.F., ET AL: "An in vivo library-versus-library selection of optimized protein-protein interactions", NATURE BIOTECHNOLOGY, vol. 17, July 1999 (1999-07-01), pages 663 - 690, XP002189201 *
REMY I ET AL: "CLONAL SELECTION AND IN VIVO QUANTITATION OF PROTEIN INTERACTONS WITH PROTEIN-FRAGMENT COMPLEMENTATION ASSAYS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, no. 10, 11 May 1999 (1999-05-11), pages 5394 - 5399, XP001008795, ISSN: 0027-8424 *
SUBRAMANIAN, R., ET AL.: "Direct visualization of protein interactions in plant cells", NATURE BIOTECHNOLOGY, vol. 19, August 2001 (2001-08-01), pages 769 - 772, XP002189157 *

Also Published As

Publication number Publication date
AU2001261408A1 (en) 2001-11-26
WO2001088168A2 (fr) 2001-11-22

Similar Documents

Publication Publication Date Title
Mayer et al. A putative modular domain present in diverse signaling proteins
EP0921395A3 (fr) Méthode pour déterminer des fragments de la protein dans les milieux biologiques
Gosink et al. Redirecting the specificity of ubiquitination by modifying ubiquitin-conjugating enzymes.
EP0930366A3 (fr) Domaines de liaison de la protéine serrate
ATE213837T1 (de) Polypeptid-dendrimer komplexe
WO2001094617A3 (fr) Essai de complementation de fragment de proteine a base de beta-lactamase du tem-1 d&#39;e. coli pour la detection des interactions entre proteine et proteine, proteine et petite molecule, et proteine et acide nucleique
WO2003029458A3 (fr) Procede pour produire des banques de proteines et selectionner des proteines a partir de ces banques
EP2172486A3 (fr) Anticorps monoclonal contre un prion et son utilisation pour la détection de prions
HK1044966A1 (zh) C端蛋白标签
WO2000032631A3 (fr) Compositions et procedes d&#39;utilisation de proteines et de peptides fixant des proteines inhibant l&#39;angiogenese
WO2002096930A3 (fr) Peptides se liant a l&#39;inhibiteur iap et dosages permettant d&#39;identifier les composes qui se lient a l&#39;inhibiteur iap
GEP20094629B (en) Nogo receptor binding protein
AU2001287000A1 (en) Modified polypeptides stabilized in a desired conformation and methods for producing same
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
AU2002223044A1 (en) Kit and method for detecting the esm-1 protein
WO2001088168A3 (fr) Mise en correspondance d&#39;interactions moleculaires dans des plantes et d&#39;analyses de complementation de fragments de proteine
WO1997012039A3 (fr) Inositol-phosphatase contenant le site sh2
KR870001311A (ko) 단백질 및 폴리펩티드의 제조 방법
AU5143099A (en) Protein fragment complementation assays for the detection of biological or drug interactions
CA2173102A1 (fr) Sequence d&#39;adn codant pour un recepteur de la proteine morphogenetique osseuse
AU2003296085A1 (en) Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
WO2005033130A3 (fr) Domaines de liaison a l&#39;ig de la proteine l, synthetiques
EP0863153A3 (fr) Protéines de la mousse, anticorps monoclonaux spécifiques et leurs applications
AU4951797A (en) Process for detecting live microbiological contaminants in food product sample
EP0931834A3 (fr) Domaine de liaison d&#39;echinocandinl de la 1,3-beta-glucane synthase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC FORM 1205A OF 20-01-03

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP